Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec;16(12):667.
doi: 10.1038/s41584-020-00535-5.

JAK1 inhibitor superior to abatacept in head-to-head RA trial

Sarah Onuora  1
Affiliations
Comment

JAK1 inhibitor superior to abatacept in head-to-head RA trial

Sarah Onuora. Nat Rev Rheumatol. 2020 Dec.
No abstract available

PubMed Disclaimer

Comment on

  • Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis.
    Rubbert-Roth A, Enejosa J, Pangan AL, Haraoui B, Rischmueller M, Khan N, Zhang Y, Martin N, Xavier RM. Rubbert-Roth A, et al. N Engl J Med. 2020 Oct 15;383(16):1511-1521. doi: 10.1056/NEJMoa2008250. N Engl J Med. 2020. PMID: 33053283 Clinical Trial.

References

Original article
    1. Rubbert-Roth, A. et al. Trial of upadacitinib or abatacept in rheumatoid arthritis. N. Engl. J. Med. 383, 1511–1521 (2020) - DOI
Related articles
    1. O’Shea, J. J. & Gadina, M. Selective Janus kinase inhibitors come of age. Nat. Rev. Rheumatol. 15, 74–75 (2020) - DOI